You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AL Amyloidosis

Showing 1 - 25 of 3,577
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Light Chain Amyloidosis Trial (FKC288)

Not yet recruiting
  • Light Chain Amyloidosis
  • (no location specified)
Jul 30, 2023

Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)

Recruiting
  • Amyloid
  • Amyloid Cardiomyopathy
  • 18F-florbetaben PET/CT
  • Pisa, Italy
    Fondazione Toscana Gabriele Monasterio
Sep 16, 2023

Light Chain (AL) Amyloidosis Trial (STI-6129)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • (no location specified)
Jan 11, 2023

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • (no location specified)
Aug 16, 2023

Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules

Not yet recruiting
  • Immunoglobulin Light-chain Amyloidosis
  • Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • (no location specified)
Mar 18, 2023

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

Recruiting
  • AL Amyloidosis
  • daratumumab and pomalidomide
  • Catanzaro, Italy
  • +2 more
Aug 3, 2022

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

AL Amyloidosis Trial in Palo Alto, Detroit, Cleveland (CAEL-101, SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD),

Active, not recruiting
  • AL Amyloidosis
  • Palo Alto, California
  • +2 more
Dec 6, 2022

AL Amyloidosis Trial in Pavia

Recruiting
  • AL Amyloidosis
    • Pavia, Italy
      Fondazione IRCCS Policlinico San Matteo
    May 4, 2022

    AL Amyloidosis Trial in Beijing

    Recruiting
    • AL Amyloidosis
      • Beijing, China
        Peking Union Medical College Hospital
      Apr 20, 2022

      AL Amyloidosis Trial in Worldwide (Belantamab mafodotin)

      Recruiting
      • AL Amyloidosis
      • Belantamab mafodotin
      • Limoges, France
      • +5 more
      Sep 26, 2022

      Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

      Withdrawn
      • Amyloidosis
      • Light Chain (AL) Amyloidosis
      • (no location specified)
      Dec 29, 2022

      Cardiac Amyloidosis, AL Amyloidosis, ATTR Amyloidosis Trial ([18F]florbetaben)

      Not yet recruiting
      • Cardiac Amyloidosis
      • +2 more
      • (no location specified)
      Apr 22, 2022

      Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

      Active, not recruiting
      • Light Chain Deposition Disease
      • Primary Systemic Amyloidosis
      • Denver, Colorado
      • +4 more
      Jan 20, 2023

      Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)

      Terminated
      • Amyloidosis; Systemic
      • Propylene Glycol-Free Melphalan Hydrochloride
      • Boston, Massachusetts
        Boston Medical Center
      Jul 1, 2022

      AL Amyloidosis, Amyloidosis Trial in Stanford, Boston, Rochester (Belantamab mafodotin 2.5 mg/kg (6 weeks), Belantamab mafodotin

      Not yet recruiting
      • AL Amyloidosis
      • Amyloidosis
      • Belantamab mafodotin 2.5 mg/kg (6 weeks)
      • +4 more
      • Stanford, California
      • +3 more
      Jul 25, 2022

      AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

      Not yet recruiting
      • AL Amyloidosis
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Aug 16, 2022

      Screening to Improve Survival in AL Amyloidosis

      Recruiting
      • Smoldering Multiple Myeloma
      • Monoclonal Gammopathy of Undetermined Significance
        • Orange, California
        • +5 more
        Nov 16, 2022

        AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)

        Not yet recruiting
        • AL Amyloidosis
        • Bone Marrow Biopsy
        • +4 more
        • Scottsdale, Arizona
        • +2 more
        Jun 2, 2023

        Amyloidosis, AL Amyloidosis Trial in Worldwide (ZN-d5)

        Recruiting
        • Amyloidosis
        • AL Amyloidosis
        • Denver, Colorado
        • +1 more
        Jan 18, 2022

        Cardiac AL Amyloidosis Trial in Worldwide (Doxycycline, Standard of care therapy)

        Active, not recruiting
        • Cardiac AL Amyloidosis
        • Edmonton, Canada
        • +7 more
        May 4, 2022

        AL Amyloidosis Trial in France (Isatuximab)

        Recruiting
        • AL Amyloidosis
        • Amiens, France
        • +14 more
        Aug 9, 2022

        Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

        Suspended
        • Amyloid
        • +2 more
        • New York, New York
          Weill Cornell Medicine - Multiple Myeloma Center
        May 17, 2022